BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36711898)

  • 1. Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein.
    Bosnakovski D; Toso EA; Ener ET; Gearhart MD; Yin L; Lüttmann FF; Magli A; Shi K; Kim J; Aihara H; Kyba M
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein.
    Bosnakovski D; Toso EA; Ener ET; Gearhart MD; Yin L; Lüttmann FF; Magli A; Shi K; Kim J; Aihara H; Kyba M
    iScience; 2023 Oct; 26(10):107823. PubMed ID: 37744032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene.
    Leidenroth A; Hewitt JE
    BMC Evol Biol; 2010 Nov; 10():364. PubMed ID: 21110847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4.
    Eidahl JO; Giesige CR; Domire JS; Wallace LM; Fowler AM; Guckes SM; Garwick-Coppens SE; Labhart P; Harper SQ
    Hum Mol Genet; 2016 Oct; 25(20):4577-4589. PubMed ID: 28173143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.
    Grow EJ; Weaver BD; Smith CM; Guo J; Stein P; Shadle SC; Hendrickson PG; Johnson NE; Butterfield RJ; Menafra R; Kloet SL; van der Maarel SM; Williams CJ; Cairns BR
    Nat Genet; 2021 Aug; 53(8):1207-1220. PubMed ID: 34267371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of DUX gene macrosatellites in placental mammals.
    Leidenroth A; Clapp J; Mitchell LM; Coneyworth D; Dearden FL; Iannuzzi L; Hewitt JE
    Chromosoma; 2012 Oct; 121(5):489-97. PubMed ID: 22903800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei.
    Jiang S; Williams K; Kong X; Zeng W; Nguyen NV; Ma X; Tawil R; Yokomori K; Mortazavi A
    PLoS Genet; 2020 May; 16(5):e1008754. PubMed ID: 32365093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis.
    Young JM; Whiddon JL; Yao Z; Kasinathan B; Snider L; Geng LN; Balog J; Tawil R; van der Maarel SM; Tapscott SJ
    PLoS Genet; 2013 Nov; 9(11):e1003947. PubMed ID: 24278031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of the Double Homeodomain of DUX4 in Complex with DNA.
    Lee JK; Bosnakovski D; Toso EA; Dinh T; Banerjee S; Bohl TE; Shi K; Orellana K; Kyba M; Aihara H
    Cell Rep; 2018 Dec; 25(11):2955-2962.e3. PubMed ID: 30540931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression.
    Bosnakovski D; Gearhart MD; Toso EA; Ener ET; Choi SH; Kyba M
    Sci Rep; 2018 Nov; 8(1):16957. PubMed ID: 30446688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.
    Wong CJ; Whiddon JL; Langford AT; Belleville AE; Tapscott SJ
    Hum Mol Genet; 2022 May; 31(10):1694-1704. PubMed ID: 34888646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DUX4 expression in cancer induces a metastable early embryonic totipotent program.
    Smith AA; Nip Y; Bennett SR; Hamm DC; Lemmers RJLF; van der Vliet PJ; Setty M; van der Maarel SM; Tapscott SJ
    Cell Rep; 2023 Sep; 42(9):113114. PubMed ID: 37691147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
    Moyle LA; Blanc E; Jaka O; Prueller J; Banerji CR; Tedesco FS; Harridge SD; Knight RD; Zammit PS
    Elife; 2016 Nov; 5():. PubMed ID: 27841748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres cooperate in zygotic genome activation by affecting
    Zhang X; Zhang C; Zhou D; Zhang T; Chen X; Ren J; He C; Meng F; Zhou Q; Yang Q; Dai C; Lin G; Zeng S; Leng L
    iScience; 2023 Mar; 26(3):106158. PubMed ID: 36843839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of DUX4 and target gene expression in FSHD myocytes.
    Chau J; Kong X; Viet Nguyen N; Williams K; Ball M; Tawil R; Kiyono T; Mortazavi A; Yokomori K
    Hum Mutat; 2021 Apr; 42(4):421-433. PubMed ID: 33502067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation and innovation in the DUX4-family gene network.
    Whiddon JL; Langford AT; Wong CJ; Zhong JW; Tapscott SJ
    Nat Genet; 2017 Jun; 49(6):935-940. PubMed ID: 28459454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interplay between two candidate genes in FSHD muscular dystrophy.
    Ferri G; Huichalaf CH; Caccia R; Gabellini D
    Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38
    Rojas LA; Valentine E; Accorsi A; Maglio J; Shen N; Robertson A; Kazmirski S; Rahl P; Tawil R; Cadavid D; Thompson LA; Ronco L; Chang AN; Cacace AM; Wallace O
    J Pharmacol Exp Ther; 2020 Sep; 374(3):489-498. PubMed ID: 32576599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
    Gatica LV; Rosa AL
    Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.